An open road

Understanding lingering long-term symptoms in patients "recovered" from a viral or bacterial infection is a long and winding road.

iStock

COVID-19 isn’t the only microbial infection to cause long-term symptoms

The long-term effects that many recovered COVID-19 patients experience, known as long COVID, seem unusual. But are they really?
| 2 min read
Written byNatalya Ortolano, PhD

My fascination with viruses started when I was in high school after I read the book The Hot Zone by Richard Preston. Preston wrote about how the Ebola virus became the lethal killer that we know today. The slow evolution of Ebola fever and its rapid spread through Africa and eventually to the United States was a real-life horror story. I’ll admit that I never considered then whether or not I would live through a pandemic one day.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

  • Natalya Ortolano, PhD Headshot

    Natalya received her PhD in from Vanderbilt University in 2021; she joined the DDN team the same week she defended her thesis. Her work has been featured at STAT News, Vanderbilt Magazine, and Scientific American. As an assistant editor, she writes and edits online and print stories on topics ranging from cows to psychedelics. Outside of work you can probably find her at a concert in her hometown Nashville, TN.

    View Full Profile

Here are some related topics that may interest you:

Published In

December 2021/January 2022 Issue
Volume 17 - Issue 12 | December 2021/January 2022

December 2021/January 2022

December 2021/January 2022 Issue

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

3D molecular rendering of antibody proteins with blue and gold surface structures floating against a soft blue background
Explore the scientific advances driving more specific, potent, and adaptable antibody-based therapies.
Gloved hand holding a microcentrifuge tube while a pipette dispenses liquid
Explore how digital PCR is reshaping sterility testing to support faster, more reliable release of advanced therapy medicinal products.
Illustration of a cell undergoing division, showing two connected daughter cells with visible nuclei, rendered in blue tones
Explore how breakthroughs in fast confocal imaging and 3D cell culture converged to transform the study of complex human biology in vitro.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue